All tenders
75A50126F61002
RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1
Department of Health and Human Services · NM, United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75A50126F61002
- Issuing organization
- Department of Health and Human Services · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1
- Source
- usaspending
- Source ID
- CONT_AWD_75A50126F61002_7505_75A50122D00021_7505
Details
- Location
- NM, United States
Description
RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1 Awarded to: LOVELACE BIOMEDICAL RESEARCH INSTITUTE Sub-agency: Office of Assistant Secretary for Preparedness and Response Contract type: DELIVERY ORDER
Dates
- Publication
- 2026/08/26 12:00:00 AM UTC
- Closing date
- 2028/04/25 12:00:00 AM UTC
Estimated value
$3.7M USD
Classification
Normalized category
Healthcare & Medical